After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NYSE listed company, CRL falls under the Healthcare sector while operating within the Diagnostics & Research industry segment. The current market capitalization of Charles River Laboratories International Inc is $8.02B. A total of 1.88 million shares were traded on the day, compared to an average of 1.07M shares.
In the most recent transaction, WALLMAN RICHARD F bought 8,500 shares of CRL for 150.00 per share on Jul 21 ’25. In a previous transaction on Jun 23 ’25, WALLMAN RICHARD F bought 4,000 shares at 137.50 per share.
Among the insiders who sold shares, MASSARO GEORGE disposed of 140 shares on May 15 ’25 at a per-share price of $137.57. This resulted in the Director holding 5,575 shares of CRL after the transaction. In another insider transaction, MASSARO GEORGE sold 140 shares at $140.73 per share on May 14 ’25. Company shares held by the Director now total 5,715.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, CRL has a high of $254.15 and a low of $91.86.
As of this writing, CRL has an earnings estimate of $2.49 per share for the current quarter. EPS was calculated based on a consensus of 14.0 estimates, with a high estimate of $2.51 per share and a lower estimate of $2.33.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. CRL’s latest balance sheet shows that the firm has $241.21M in Cash & Short Term Investments as of fiscal 2021. There were $2.92B in debt and $1.03B in liabilities at the time. Its Book Value Per Share was $65.04, while its Total Shareholder’s Equity was $2.59B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CRL is Buy with a score of 3.67.
